Research Paper Volume 14, Issue 17 pp 7170—7185
A circadian rhythm-related gene signature for predicting relapse risk and immunotherapeutic effect in prostate adenocarcinoma
Figure 8. The profiling of somatic nucleotide variation for PRAD patients of different risk groups. (A, B) The waterfall plot of nucleotide variation rate in high-risk group and low-risk group. (C, D) The bar plot and box plot analyses of risk scores in the high-mutation group and low-mutation group. (E) The correlation of tumor mutation burden and risk score. *P <0.05, ** P <0.01, ***P<0.001.